Potential biomarkers for Alzheimer’s disease (AD) include amyloid β1–42 (Aβ1–42), t-Tau, p-Tau181, neurofilament light chain (NFL), and neuroimaging biomarkers. This evidence concerns the gene NEFL and early-onset autosomal dominant Alzheimer disease.